Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
$8.93 → $8.96 · observed estimates
NYSEConsumer StaplesSpecialty RetailSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 8, 2026.
Next-FY EPS estimate change · 30 days
8.93 → 8.96 EPS · FY ending Dec 31, 2027 · 7 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 7 to 7; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for MNSO yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
successful product launches | Recent pop-up events and product launches enhance customer engagement. | Intact | fewer than 2 successful launches in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
$8.93 → $8.96 · observed estimates
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 19, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is best described as a consumer-sector business with elevated risk, but the evidence is too thin to classify its long-term profile more firmly. The thesis state is insufficient because there is not enough recent financial performance history.
The snapshot provides no valuation or market-expectations evidence, so it is not possible to say whether the shares look cheap, fair, or expensive versus peers. The market’s assumptions are also unclear.
The evidence points to a near-term concern: MNSO has missed earnings across recent quarters, although the stated miss risk is low. The broader Consumer Staples backdrop is a tailwind for now, but weakening jobs data could increase recession concerns for cyclical names.
Near term, the thesis depends partly on whether jobs data keeps weakening and whether sector bellwether CASY continues to beat earnings and guide higher. CASY misses or lower guidance could weaken the sector tailwind; confidence in this assessment is low.
For the next 1 to 3 years, the long-term thesis remains unclear because company-specific financial evidence and valuation context are missing. Recent earnings misses and elevated risk matter, while the sector backdrop is a possible support. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in MINISO GROUP HOLDING LTD's published investment case. The stated target is >=8.39. |
| Under Pressure |
| falls below $8 in FY26 |
Diluted EPS: CNY 4.08 per share FY2026-Q1; GAAP. Published target: >=8.39. Annual target cannot be compared with a quarterly or TTM observation. May 27, 20264.08 CNY/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
FY26 revenue growth | A primary condition in MINISO GROUP HOLDING LTD's published investment case. The stated target is >=24.77 billion. | Intact | falls below $24 billion in FY26 | Revenue: CNY 5.654B FY2026-Q1; GAAP. Published target: >=24.77 billion. Annual target cannot be compared with a quarterly or TTM observation. May 27, 20265,653,984,188 CNY · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Oct 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$27.44B → $27.63B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-10-05 | $8.93 | $27,444,486,421 | 7 / 13 |
| 2026-10-06 | $8.93 | $27,444,486,421 | 7 / 13 |
| 2026-10-07 | $8.94 | $27,477,656,418 | 7 / 13 |
| 2026-10-08 | $8.94 | $27,472,128,085 | 7 / 13 |
| 2026-10-09 | $8.94 | $27,466,599,752 | 7 / 13 |
| 2026-10-10 | $8.94 | $27,466,599,752 | 7 / 13 |
| 2026-10-11 | $8.90 | $27,464,756,975 | 7 / 13 |
| 2026-10-12 | $8.90 | $27,460,770,005 | 7 / 13 |
| 2026-10-13 | $8.72 | $27,549,494,013 | 7 / 13 |
| 2026-10-14 | $8.72 | $27,549,939,177 | 7 / 13 |
| 2026-10-15 | $8.72 | $27,549,802,203 | 7 / 13 |
| 2026-10-16 | $8.72 | $27,558,823,434 | 7 / 13 |
| 2026-10-17 | $8.72 | $27,558,823,434 | 7 / 13 |
| 2026-10-18 | $8.72 | $27,558,823,434 | 7 / 13 |
| 2026-10-19 | $8.72 | $27,558,823,434 | 7 / 13 |
| 2026-10-20 | $8.73 | $27,582,800,459 | 7 / 13 |
| 2026-10-21 | $8.83 | $27,606,776,631 | 7 / 13 |
| 2026-10-22 | $8.83 | $27,606,776,631 | 7 / 13 |
| 2026-10-23 | $8.95 | $27,606,776,631 | 7 / 13 |
| 2026-10-24 | $8.95 | $27,606,776,631 | 7 / 13 |
| 2026-10-25 | $8.95 | $27,606,776,631 | 7 / 13 |
| 2026-10-26 | $8.95 | $27,606,776,631 | 7 / 13 |
| 2026-10-27 | $8.95 | $27,606,776,631 | 7 / 13 |
| 2026-10-28 | $8.96 | $27,630,753,655 | 7 / 13 |
| 2026-10-29 | $8.97 | $27,662,108,225 | 7 / 13 |
| 2026-10-30 | $8.97 | $27,649,197,520 | 7 / 13 |
| 2026-10-31 | $8.98 | $27,682,396,476 | 7 / 13 |
| 2026-11-01 | $8.98 | $27,682,396,476 | 7 / 13 |
| 2026-11-02 | $8.99 | $27,711,906,660 | 7 / 13 |
| 2026-11-03 | $8.99 | $27,730,552,837 | 7 / 13 |
| 2026-11-04 | $8.96 | $27,634,618,518 | 7 / 13 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 13 Buy / Strong Buy · 4 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.